Table 3.
Adverse financial outcomes due to cancer
| Characteristic | Total No. | Financial hardship, No. (%) | Unadjusted PRa (95% CI) | Adjusted PRa,b (95% CI) |
|---|---|---|---|---|
| Overall | 1628 | 342 (21.0) | ||
| No employment disruption | 1184 | 182 (15.4) | 1 | 1 |
| Employment disruption | 444 | 160 (36.0) | 2.34 (1.95 to 2.81) | 1.93 (1.58 to 2.35) |
| Stratified by race or ethnicity | ||||
| Non-Hispanic White | 1448 | 290 (20.0) | 2.28 (1.87 to 2.79) | 1.91 (1.54 to 2.37) |
| Non-Hispanic Black | 79 | 23 (29.1) | 4.59 (2.36 to 8.94) | 3.14 (1.61 to 6.14) |
| Hispanic | 57 | 16 (28.1) | 1.41 (0.61 to 3.26) | 1.11 (0.46 to 2.70) |
| Non-Hispanic all other races | 44 | 13 (29.5) | 2.11 (0.82 to 5.42) | 1.90 (0.76 to 4.74) |
Comparing women with employment disruption with women without employment disruption. CI = confidence interval; PR = prevalence ratio.
Adjusted for age at diagnosis, region of residence at enrollment, race or ethnicity, education, marital or partner status at diagnosis, caregiving for someone else during treatment, type of employment at diagnosis, paid leave, health insurance during treatment, prediagnosis comorbidities, cancer stage, and time since last surgery, radiation, or chemotherapy. Twelve women who reported no insurance were included with women without private health insurance, with minimal influence on the analysis compared with excluding these women. Excludes women with missing covariate data (n = 42).